Global Transdermal Analgesic Patch Market Growth 2022-2028
The global market for Transdermal Analgesic Patch is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Transdermal Analgesic Patch market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Transdermal Analgesic Patch market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Transdermal Analgesic Patch market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Transdermal Analgesic Patch market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Transdermal Analgesic Patch players cover Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, UCB Pharma and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Transdermal Analgesic Patch market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Transdermal Analgesic Patch market, with both quantitative and qualitative data, to help readers understand how the Transdermal Analgesic Patch market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Transdermal Analgesic Patch market and forecasts the market size by Type (Methyl Salicylate-based Patch, Rivastigmine Transdermal Patch and Fentanyl Transdermal Patch), by Channel (Rx Channel and OTC Channel.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Segmentation by channel
Rx Channel
OTC Channel
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Hisamitsu Pharmaceutical
Johnson & Johnson
Mylan
UCB Pharma
Novartis
Teva Pharmaceutical
Beijing Tide Pharmaceutical
Chattem
Nitto Denko
Grünenthal
Mundipharma
GSK
Luye Pharma Group
Bayer
IBSA Group
Dr Reddy's Laboratories
Chapter Introduction
Chapter 1: Scope of Transdermal Analgesic Patch, Research Methodology, etc.
Chapter 2: Executive Summary, global Transdermal Analgesic Patch market size (sales and revenue) and CAGR, Transdermal Analgesic Patch market size by region, by type, by channel, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Transdermal Analgesic Patch sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Transdermal Analgesic Patch sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Transdermal Analgesic Patch market size forecast by region, by country, by type, and channel.
Chapter 13: Comprehensive company profiles of the leading players, including Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, UCB Pharma, Novartis, Teva Pharmaceutical, Beijing Tide Pharmaceutical, Chattem and Nitto Denko, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transdermal Analgesic Patch Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Transdermal Analgesic Patch by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Transdermal Analgesic Patch by Country/Region, 2017, 2022 & 2028
2.2 Transdermal Analgesic Patch Segment by Type
2.2.1 Methyl Salicylate-based Patch
2.2.2 Rivastigmine Transdermal Patch
2.2.3 Fentanyl Transdermal Patch
2.2.4 Lidocaine Patch
2.2.5 Diclofenac Patch
2.2.6 Nicotine Transdermal Patch
2.2.7 Others
2.3 Transdermal Analgesic Patch Sales by Type
2.3.1 Global Transdermal Analgesic Patch Sales Market Share by Type (2017-2022)
2.3.2 Global Transdermal Analgesic Patch Revenue and Market Share by Type (2017-2022)
2.3.3 Global Transdermal Analgesic Patch Sale Price by Type (2017-2022)
2.4 Transdermal Analgesic Patch Segment by Channel
2.4.1 Rx Channel
2.4.2 OTC Channel
2.5 Transdermal Analgesic Patch Sales by Channel
2.5.1 Global Transdermal Analgesic Patch Sale Market Share by Channel (2017-2022)
2.5.2 Global Transdermal Analgesic Patch Revenue and Market Share by Channel (2017-2022)
2.5.3 Global Transdermal Analgesic Patch Sale Price by Channel (2017-2022)
3 Global Transdermal Analgesic Patch by Company
3.1 Global Transdermal Analgesic Patch Breakdown Data by Company
3.1.1 Global Transdermal Analgesic Patch Annual Sales by Company (2020-2022)
3.1.2 Global Transdermal Analgesic Patch Sales Market Share by Company (2020-2022)
3.2 Global Transdermal Analgesic Patch Annual Revenue by Company (2020-2022)
3.2.1 Global Transdermal Analgesic Patch Revenue by Company (2020-2022)
3.2.2 Global Transdermal Analgesic Patch Revenue Market Share by Company (2020-2022)
3.3 Global Transdermal Analgesic Patch Sale Price by Company
3.4 Key Manufacturers Transdermal Analgesic Patch Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Transdermal Analgesic Patch Product Location Distribution
3.4.2 Players Transdermal Analgesic Patch Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Transdermal Analgesic Patch by Geographic Region
4.1 World Historic Transdermal Analgesic Patch Market Size by Geographic Region (2017-2022)
4.1.1 Global Transdermal Analgesic Patch Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Transdermal Analgesic Patch Annual Revenue by Geographic Region
4.2 World Historic Transdermal Analgesic Patch Market Size by Country/Region (2017-2022)
4.2.1 Global Transdermal Analgesic Patch Annual Sales by Country/Region (2017-2022)
4.2.2 Global Transdermal Analgesic Patch Annual Revenue by Country/Region
4.3 Americas Transdermal Analgesic Patch Sales Growth
4.4 APAC Transdermal Analgesic Patch Sales Growth
4.5 Europe Transdermal Analgesic Patch Sales Growth
4.6 Middle East & Africa Transdermal Analgesic Patch Sales Growth
5 Americas
5.1 Americas Transdermal Analgesic Patch Sales by Country
5.1.1 Americas Transdermal Analgesic Patch Sales by Country (2017-2022)
5.1.2 Americas Transdermal Analgesic Patch Revenue by Country (2017-2022)
5.2 Americas Transdermal Analgesic Patch Sales by Type
5.3 Americas Transdermal Analgesic Patch Sales by Channel
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transdermal Analgesic Patch Sales by Region
6.1.1 APAC Transdermal Analgesic Patch Sales by Region (2017-2022)
6.1.2 APAC Transdermal Analgesic Patch Revenue by Region (2017-2022)
6.2 APAC Transdermal Analgesic Patch Sales by Type
6.3 APAC Transdermal Analgesic Patch Sales by Channel
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Transdermal Analgesic Patch by Country
7.1.1 Europe Transdermal Analgesic Patch Sales by Country (2017-2022)
7.1.2 Europe Transdermal Analgesic Patch Revenue by Country (2017-2022)
7.2 Europe Transdermal Analgesic Patch Sales by Type
7.3 Europe Transdermal Analgesic Patch Sales by Channel
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Transdermal Analgesic Patch by Country
8.1.1 Middle East & Africa Transdermal Analgesic Patch Sales by Country (2017-2022)
8.1.2 Middle East & Africa Transdermal Analgesic Patch Revenue by Country (2017-2022)
8.2 Middle East & Africa Transdermal Analgesic Patch Sales by Type
8.3 Middle East & Africa Transdermal Analgesic Patch Sales by Channel
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Transdermal Analgesic Patch
10.3 Manufacturing Process Analysis of Transdermal Analgesic Patch
10.4 Industry Chain Structure of Transdermal Analgesic Patch
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Transdermal Analgesic Patch Distributors
11.3 Transdermal Analgesic Patch Customer
12 World Forecast Review for Transdermal Analgesic Patch by Geographic Region
12.1 Global Transdermal Analgesic Patch Market Size Forecast by Region
12.1.1 Global Transdermal Analgesic Patch Forecast by Region (2023-2028)
12.1.2 Global Transdermal Analgesic Patch Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Transdermal Analgesic Patch Forecast by Type
12.7 Global Transdermal Analgesic Patch Forecast by Channel
13 Key Players Analysis
13.1 Hisamitsu Pharmaceutical
13.1.1 Hisamitsu Pharmaceutical Company Information
13.1.2 Hisamitsu Pharmaceutical Transdermal Analgesic Patch Product Offered
13.1.3 Hisamitsu Pharmaceutical Transdermal Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Hisamitsu Pharmaceutical Main Business Overview
13.1.5 Hisamitsu Pharmaceutical Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson Transdermal Analgesic Patch Product Offered
13.2.3 Johnson & Johnson Transdermal Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Transdermal Analgesic Patch Product Offered
13.3.3 Mylan Transdermal Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 UCB Pharma
13.4.1 UCB Pharma Company Information
13.4.2 UCB Pharma Transdermal Analgesic Patch Product Offered
13.4.3 UCB Pharma Transdermal Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 UCB Pharma Main Business Overview
13.4.5 UCB Pharma Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis Transdermal Analgesic Patch Product Offered
13.5.3 Novartis Transdermal Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Teva Pharmaceutical
13.6.1 Teva Pharmaceutical Company Information
13.6.2 Teva Pharmaceutical Transdermal Analgesic Patch Product Offered
13.6.3 Teva Pharmaceutical Transdermal Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Teva Pharmaceutical Main Business Overview
13.6.5 Teva Pharmaceutical Latest Developments
13.7 Beijing Tide Pharmaceutical
13.7.1 Beijing Tide Pharmaceutical Company Information
13.7.2 Beijing Tide Pharmaceutical Transdermal Analgesic Patch Product Offered
13.7.3 Beijing Tide Pharmaceutical Transdermal Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Beijing Tide Pharmaceutical Main Business Overview
13.7.5 Beijing Tide Pharmaceutical Latest Developments
13.8 Chattem
13.8.1 Chattem Company Information
13.8.2 Chattem Transdermal Analgesic Patch Product Offered
13.8.3 Chattem Transdermal Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Chattem Main Business Overview
13.8.5 Chattem Latest Developments
13.9 Nitto Denko
13.9.1 Nitto Denko Company Information
13.9.2 Nitto Denko Transdermal Analgesic Patch Product Offered
13.9.3 Nitto Denko Transdermal Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Nitto Denko Main Business Overview
13.9.5 Nitto Denko Latest Developments
13.10 Grünenthal
13.10.1 Grünenthal Company Information
13.10.2 Grünenthal Transdermal Analgesic Patch Product Offered
13.10.3 Grünenthal Transdermal Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Grünenthal Main Business Overview
13.10.5 Grünenthal Latest Developments
13.11 Mundipharma
13.11.1 Mundipharma Company Information
13.11.2 Mundipharma Transdermal Analgesic Patch Product Offered
13.11.3 Mundipharma Transdermal Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Mundipharma Main Business Overview
13.11.5 Mundipharma Latest Developments
13.12 GSK
13.12.1 GSK Company Information
13.12.2 GSK Transdermal Analgesic Patch Product Offered
13.12.3 GSK Transdermal Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 GSK Main Business Overview
13.12.5 GSK Latest Developments
13.13 Luye Pharma Group
13.13.1 Luye Pharma Group Company Information
13.13.2 Luye Pharma Group Transdermal Analgesic Patch Product Offered
13.13.3 Luye Pharma Group Transdermal Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Luye Pharma Group Main Business Overview
13.13.5 Luye Pharma Group Latest Developments
13.14 Bayer
13.14.1 Bayer Company Information
13.14.2 Bayer Transdermal Analgesic Patch Product Offered
13.14.3 Bayer Transdermal Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Bayer Main Business Overview
13.14.5 Bayer Latest Developments
13.15 IBSA Group
13.15.1 IBSA Group Company Information
13.15.2 IBSA Group Transdermal Analgesic Patch Product Offered
13.15.3 IBSA Group Transdermal Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 IBSA Group Main Business Overview
13.15.5 IBSA Group Latest Developments
13.16 Dr Reddy's Laboratories
13.16.1 Dr Reddy's Laboratories Company Information
13.16.2 Dr Reddy's Laboratories Transdermal Analgesic Patch Product Offered
13.16.3 Dr Reddy's Laboratories Transdermal Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Dr Reddy's Laboratories Main Business Overview
13.16.5 Dr Reddy's Laboratories Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Transdermal Analgesic Patch Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Transdermal Analgesic Patch Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Methyl Salicylate-based Patch
Table 4. Major Players of Rivastigmine Transdermal Patch
Table 5. Major Players of Fentanyl Transdermal Patch
Table 6. Major Players of Lidocaine Patch
Table 7. Major Players of Diclofenac Patch
Table 8. Major Players of Nicotine Transdermal Patch
Table 9. Major Players of Others
Table 10. Global Transdermal Analgesic Patch Sales by Type (2017-2022) & (K Units)
Table 11. Global Transdermal Analgesic Patch Sales Market Share by Type (2017-2022)
Table 12. Global Transdermal Analgesic Patch Revenue by Type (2017-2022) & ($ million)
Table 13. Global Transdermal Analgesic Patch Revenue Market Share by Type (2017-2022)
Table 14. Global Transdermal Analgesic Patch Sale Price by Type (2017-2022) & (US$/Unit)
Table 15. Global Transdermal Analgesic Patch Sales by Channel (2017-2022) & (K Units)
Table 16. Global Transdermal Analgesic Patch Sales Market Share by Channel (2017-2022)
Table 17. Global Transdermal Analgesic Patch Revenue by Channel (2017-2022)
Table 18. Global Transdermal Analgesic Patch Revenue Market Share by Channel (2017-2022)
Table 19. Global Transdermal Analgesic Patch Sale Price by Channel (2017-2022) & (US$/Unit)
Table 20. Global Transdermal Analgesic Patch Sales by Company (2020-2022) & (K Units)
Table 21. Global Transdermal Analgesic Patch Sales Market Share by Company (2020-2022)
Table 22. Global Transdermal Analgesic Patch Revenue by Company (2020-2022) ($ Millions)
Table 23. Global Transdermal Analgesic Patch Revenue Market Share by Company (2020-2022)
Table 24. Global Transdermal Analgesic Patch Sale Price by Company (2020-2022) & (US$/Unit)
Table 25. Key Manufacturers Transdermal Analgesic Patch Producing Area Distribution and Sales Area
Table 26. Players Transdermal Analgesic Patch Products Offered
Table 27. Transdermal Analgesic Patch Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Transdermal Analgesic Patch Sales by Geographic Region (2017-2022) & (K Units)
Table 31. Global Transdermal Analgesic Patch Sales Market Share Geographic Region (2017-2022)
Table 32. Global Transdermal Analgesic Patch Revenue by Geographic Region (2017-2022) & ($ millions)
Table 33. Global Transdermal Analgesic Patch Revenue Market Share by Geographic Region (2017-2022)
Table 34. Global Transdermal Analgesic Patch Sales by Country/Region (2017-2022) & (K Units)
Table 35. Global Transdermal Analgesic Patch Sales Market Share by Country/Region (2017-2022)
Table 36. Global Transdermal Analgesic Patch Revenue by Country/Region (2017-2022) & ($ millions)
Table 37. Global Transdermal Analgesic Patch Revenue Market Share by Country/Region (2017-2022)
Table 38. Americas Transdermal Analgesic Patch Sales by Country (2017-2022) & (K Units)
Table 39. Americas Transdermal Analgesic Patch Sales Market Share by Country (2017-2022)
Table 40. Americas Transdermal Analgesic Patch Revenue by Country (2017-2022) & ($ Millions)
Table 41. Americas Transdermal Analgesic Patch Revenue Market Share by Country (2017-2022)
Table 42. Americas Transdermal Analgesic Patch Sales by Type (2017-2022) & (K Units)
Table 43. Americas Transdermal Analgesic Patch Sales Market Share by Type (2017-2022)
Table 44. Americas Transdermal Analgesic Patch Sales by Channel (2017-2022) & (K Units)
Table 45. Americas Transdermal Analgesic Patch Sales Market Share by Channel (2017-2022)
Table 46. APAC Transdermal Analgesic Patch Sales by Region (2017-2022) & (K Units)
Table 47. APAC Transdermal Analgesic Patch Sales Market Share by Region (2017-2022)
Table 48. APAC Transdermal Analgesic Patch Revenue by Region (2017-2022) & ($ Millions)
Table 49. APAC Transdermal Analgesic Patch Revenue Market Share by Region (2017-2022)
Table 50. APAC Transdermal Analgesic Patch Sales by Type (2017-2022) & (K Units)
Table 51. APAC Transdermal Analgesic Patch Sales Market Share by Type (2017-2022)
Table 52. APAC Transdermal Analgesic Patch Sales by Channel (2017-2022) & (K Units)
Table 53. APAC Transdermal Analgesic Patch Sales Market Share by Channel (2017-2022)
Table 54. Europe Transdermal Analgesic Patch Sales by Country (2017-2022) & (K Units)
Table 55. Europe Transdermal Analgesic Patch Sales Market Share by Country (2017-2022)
Table 56. Europe Transdermal Analgesic Patch Revenue by Country (2017-2022) & ($ Millions)
Table 57. Europe Transdermal Analgesic Patch Revenue Market Share by Country (2017-2022)
Table 58. Europe Transdermal Analgesic Patch Sales by Type (2017-2022) & (K Units)
Table 59. Europe Transdermal Analgesic Patch Sales Market Share by Type (2017-2022)
Table 60. Europe Transdermal Analgesic Patch Sales by Channel (2017-2022) & (K Units)
Table 61. Europe Transdermal Analgesic Patch Sales Market Share by Channel (2017-2022)
Table 62. Middle East & Africa Transdermal Analgesic Patch Sales by Country (2017-2022) & (K Units)
Table 63. Middle East & Africa Transdermal Analgesic Patch Sales Market Share by Country (2017-2022)
Table 64. Middle East & Africa Transdermal Analgesic Patch Revenue by Country (2017-2022) & ($ Millions)
Table 65. Middle East & Africa Transdermal Analgesic Patch Revenue Market Share by Country (2017-2022)
Table 66. Middle East & Africa Transdermal Analgesic Patch Sales by Type (2017-2022) & (K Units)
Table 67. Middle East & Africa Transdermal Analgesic Patch Sales Market Share by Type (2017-2022)
Table 68. Middle East & Africa Transdermal Analgesic Patch Sales by Channel (2017-2022) & (K Units)
Table 69. Middle East & Africa Transdermal Analgesic Patch Sales Market Share by Channel (2017-2022)
Table 70. Key Market Drivers & Growth Opportunities of Transdermal Analgesic Patch
Table 71. Key Market Challenges & Risks of Transdermal Analgesic Patch
Table 72. Key Industry Trends of Transdermal Analgesic Patch
Table 73. Transdermal Analgesic Patch Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Transdermal Analgesic Patch Distributors List
Table 76. Transdermal Analgesic Patch Customer List
Table 77. Global Transdermal Analgesic Patch Sales Forecast by Region (2023-2028) & (K Units)
Table 78. Global Transdermal Analgesic Patch Sales Market Forecast by Region
Table 79. Global Transdermal Analgesic Patch Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Global Transdermal Analgesic Patch Revenue Market Share Forecast by Region (2023-2028)
Table 81. Americas Transdermal Analgesic Patch Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Americas Transdermal Analgesic Patch Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. APAC Transdermal Analgesic Patch Sales Forecast by Region (2023-2028) & (K Units)
Table 84. APAC Transdermal Analgesic Patch Revenue Forecast by Region (2023-2028) & ($ millions)
Table 85. Europe Transdermal Analgesic Patch Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Europe Transdermal Analgesic Patch Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Middle East & Africa Transdermal Analgesic Patch Sales Forecast by Country (2023-2028) & (K Units)
Table 88. Middle East & Africa Transdermal Analgesic Patch Revenue Forecast by Country (2023-2028) & ($ millions)
Table 89. Global Transdermal Analgesic Patch Sales Forecast by Type (2023-2028) & (K Units)
Table 90. Global Transdermal Analgesic Patch Sales Market Share Forecast by Type (2023-2028)
Table 91. Global Transdermal Analgesic Patch Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 92. Global Transdermal Analgesic Patch Revenue Market Share Forecast by Type (2023-2028)
Table 93. Global Transdermal Analgesic Patch Sales Forecast by Channel (2023-2028) & (K Units)
Table 94. Global Transdermal Analgesic Patch Sales Market Share Forecast by Channel (2023-2028)
Table 95. Global Transdermal Analgesic Patch Revenue Forecast by Channel (2023-2028) & ($ Millions)
Table 96. Global Transdermal Analgesic Patch Revenue Market Share Forecast by Channel (2023-2028)
Table 97. Hisamitsu Pharmaceutical Basic Information, Transdermal Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 98. Hisamitsu Pharmaceutical Transdermal Analgesic Patch Product Offered
Table 99. Hisamitsu Pharmaceutical Transdermal Analgesic Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Hisamitsu Pharmaceutical Main Business
Table 101. Hisamitsu Pharmaceutical Latest Developments
Table 102. Johnson & Johnson Basic Information, Transdermal Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 103. Johnson & Johnson Transdermal Analgesic Patch Product Offered
Table 104. Johnson & Johnson Transdermal Analgesic Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Johnson & Johnson Main Business
Table 106. Johnson & Johnson Latest Developments
Table 107. Mylan Basic Information, Transdermal Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 108. Mylan Transdermal Analgesic Patch Product Offered
Table 109. Mylan Transdermal Analgesic Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Mylan Main Business
Table 111. Mylan Latest Developments
Table 112. UCB Pharma Basic Information, Transdermal Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 113. UCB Pharma Transdermal Analgesic Patch Product Offered
Table 114. UCB Pharma Transdermal Analgesic Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. UCB Pharma Main Business
Table 116. UCB Pharma Latest Developments
Table 117. Novartis Basic Information, Transdermal Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 118. Novartis Transdermal Analgesic Patch Product Offered
Table 119. Novartis Transdermal Analgesic Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Novartis Main Business
Table 121. Novartis Latest Developments
Table 122. Teva Pharmaceutical Basic Information, Transdermal Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 123. Teva Pharmaceutical Transdermal Analgesic Patch Product Offered
Table 124. Teva Pharmaceutical Transdermal Analgesic Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Teva Pharmaceutical Main Business
Table 126. Teva Pharmaceutical Latest Developments
Table 127. Beijing Tide Pharmaceutical Basic Information, Transdermal Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 128. Beijing Tide Pharmaceutical Transdermal Analgesic Patch Product Offered
Table 129. Beijing Tide Pharmaceutical Transdermal Analgesic Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Beijing Tide Pharmaceutical Main Business
Table 131. Beijing Tide Pharmaceutical Latest Developments
Table 132. Chattem Basic Information, Transdermal Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 133. Chattem Transdermal Analgesic Patch Product Offered
Table 134. Chattem Transdermal Analgesic Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Chattem Main Business
Table 136. Chattem Latest Developments
Table 137. Nitto Denko Basic Information, Transdermal Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 138. Nitto Denko Transdermal Analgesic Patch Product Offered
Table 139. Nitto Denko Transdermal Analgesic Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Nitto Denko Main Business
Table 141. Nitto Denko Latest Developments
Table 142. Grünenthal Basic Information, Transdermal Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 143. Grünenthal Transdermal Analgesic Patch Product Offered
Table 144. Grünenthal Transdermal Analgesic Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Grünenthal Main Business
Table 146. Grünenthal Latest Developments
Table 147. Mundipharma Basic Information, Transdermal Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 148. Mundipharma Transdermal Analgesic Patch Product Offered
Table 149. Mundipharma Transdermal Analgesic Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Mundipharma Main Business
Table 151. Mundipharma Latest Developments
Table 152. GSK Basic Information, Transdermal Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 153. GSK Transdermal Analgesic Patch Product Offered
Table 154. GSK Transdermal Analgesic Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. GSK Main Business
Table 156. GSK Latest Developments
Table 157. Luye Pharma Group Basic Information, Transdermal Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 158. Luye Pharma Group Transdermal Analgesic Patch Product Offered
Table 159. Luye Pharma Group Transdermal Analgesic Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Luye Pharma Group Main Business
Table 161. Luye Pharma Group Latest Developments
Table 162. Bayer Basic Information, Transdermal Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 163. Bayer Transdermal Analgesic Patch Product Offered
Table 164. Bayer Transdermal Analgesic Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Bayer Main Business
Table 166. Bayer Latest Developments
Table 167. IBSA Group Basic Information, Transdermal Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 168. IBSA Group Transdermal Analgesic Patch Product Offered
Table 169. IBSA Group Transdermal Analgesic Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 170. IBSA Group Main Business
Table 171. IBSA Group Latest Developments
Table 172. Dr Reddy's Laboratories Basic Information, Transdermal Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
Table 173. Dr Reddy's Laboratories Transdermal Analgesic Patch Product Offered
Table 174. Dr Reddy's Laboratories Transdermal Analgesic Patch Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 175. Dr Reddy's Laboratories Main Business
Table 176. Dr Reddy's Laboratories Latest Developments
List of Figures
Figure 1. Picture of Transdermal Analgesic Patch
Figure 2. Transdermal Analgesic Patch Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Transdermal Analgesic Patch Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Transdermal Analgesic Patch Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Transdermal Analgesic Patch Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Methyl Salicylate-based Patch
Figure 10. Product Picture of Rivastigmine Transdermal Patch
Figure 11. Product Picture of Fentanyl Transdermal Patch
Figure 12. Product Picture of Lidocaine Patch
Figure 13. Product Picture of Diclofenac Patch
Figure 14. Product Picture of Nicotine Transdermal Patch
Figure 15. Product Picture of Others
Figure 16. Global Transdermal Analgesic Patch Sales Market Share by Type in 2021
Figure 17. Global Transdermal Analgesic Patch Revenue Market Share by Type (2017-2022)
Figure 18. Transdermal Analgesic Patch Consumed in Rx Channel
Figure 19. Global Transdermal Analgesic Patch Market: Rx Channel (2017-2022) & (K Units)
Figure 20. Transdermal Analgesic Patch Consumed in OTC Channel
Figure 21. Global Transdermal Analgesic Patch Market: OTC Channel (2017-2022) & (K Units)
Figure 22. Global Transdermal Analgesic Patch Sales Market Share by Channel (2017-2022)
Figure 23. Global Transdermal Analgesic Patch Revenue Market Share by Channel in 2021
Figure 24. Transdermal Analgesic Patch Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Transdermal Analgesic Patch Revenue Market Share by Company in 2021
Figure 26. Global Transdermal Analgesic Patch Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Transdermal Analgesic Patch Revenue Market Share by Geographic Region in 2021
Figure 28. Global Transdermal Analgesic Patch Sales Market Share by Region (2017-2022)
Figure 29. Global Transdermal Analgesic Patch Revenue Market Share by Country/Region in 2021
Figure 30. Americas Transdermal Analgesic Patch Sales 2017-2022 (K Units)
Figure 31. Americas Transdermal Analgesic Patch Revenue 2017-2022 ($ Millions)
Figure 32. APAC Transdermal Analgesic Patch Sales 2017-2022 (K Units)
Figure 33. APAC Transdermal Analgesic Patch Revenue 2017-2022 ($ Millions)
Figure 34. Europe Transdermal Analgesic Patch Sales 2017-2022 (K Units)
Figure 35. Europe Transdermal Analgesic Patch Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Transdermal Analgesic Patch Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa Transdermal Analgesic Patch Revenue 2017-2022 ($ Millions)
Figure 38. Americas Transdermal Analgesic Patch Sales Market Share by Country in 2021
Figure 39. Americas Transdermal Analgesic Patch Revenue Market Share by Country in 2021
Figure 40. United States Transdermal Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Transdermal Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Transdermal Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Transdermal Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Transdermal Analgesic Patch Sales Market Share by Region in 2021
Figure 45. APAC Transdermal Analgesic Patch Revenue Market Share by Regions in 2021
Figure 46. China Transdermal Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Transdermal Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Transdermal Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Transdermal Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Transdermal Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Transdermal Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Transdermal Analgesic Patch Sales Market Share by Country in 2021
Figure 53. Europe Transdermal Analgesic Patch Revenue Market Share by Country in 2021
Figure 54. Germany Transdermal Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Transdermal Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Transdermal Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Transdermal Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Transdermal Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Transdermal Analgesic Patch Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Transdermal Analgesic Patch Revenue Market Share by Country in 2021
Figure 61. Egypt Transdermal Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Transdermal Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Transdermal Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Transdermal Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Transdermal Analgesic Patch Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Transdermal Analgesic Patch in 2021
Figure 67. Manufacturing Process Analysis of Transdermal Analgesic Patch
Figure 68. Industry Chain Structure of Transdermal Analgesic Patch
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets